http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20107053

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 243
issn 1387-2877
1875-8908
issueIdentifier 2
pageRange 243-243
publicationName Journal of Alzheimer's disease : JAD
startingPage 243
bibliographicCitation Ryan JM, Grundman M. Anti-amyloid-beta immunotherapy in Alzheimer's disease: ACC-001 clinical trials are ongoing. J Alzheimers Dis. 2009;17(2):243. doi: 10.3233/jad-2009-1118. PMID: 19502708.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b86e7af0506f6b9c71f269706ce7a487
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ae0740d811c2257dee275d5dfb6b4b6
date 2009-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19502708
https://doi.org/10.3233/jad-2009-1118
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Anti-amyloid-beta immunotherapy in Alzheimer's disease: ACC-001 clinical trials are ongoing
discusses http://id.nlm.nih.gov/mesh/M0001352
http://id.nlm.nih.gov/mesh/M0024786
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D002986
http://id.nlm.nih.gov/mesh/D007167
http://id.nlm.nih.gov/mesh/D000544Q000628
http://id.nlm.nih.gov/mesh/D016229Q000276
http://id.nlm.nih.gov/mesh/D000906Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D006801

Total number of triples: 29.